Differences in Redox Biomarkers in Bronchoalveolar Lavage Fluid of Leisure Horses With and Without Severe Equine Asthma: Preliminary Results.

Overview

• This study investigates differences in oxidative stress biomarkers in the lung fluid of leisure horses with and without severe equine asthma (SEA).
• The research identifies altered redox balance in asthmatic horses, suggesting oxidative stress plays a role in disease development.

Background

• Equine asthma is a chronic respiratory disease common in horses, marked by airway inflammation.
• Severe equine asthma (SEA) involves a significant oxidative imbalance, which can worsen lung function.
• Oxidative stress results from an imbalance between pro-oxidants (substances that promote oxidation) and antioxidants (substances that inhibit oxidation), leading to tissue damage.
• Measuring oxidative stress biomarkers in lung fluids can provide insight into disease mechanisms and severity.

Aim of the Study

• To evaluate and compare oxidative stress biomarkers in bronchoalveolar lavage fluid (BALF) from horses with SEA and those without (non-SEA).
• The study focuses on pro-oxidative substances, oxidation products, and antioxidant defense markers to understand redox balance in the lungs.

Methodology

• Design: Prospective observational study.
• Subjects: 21 leisure horses categorized as SEA or non-SEA based on clinical history and BALF cytology.
• Sample collection: Bronchoalveolar lavage fluid (BALF) was collected from the horses’ lungs.
• Analytical measurements were made for the following biomarkers:
  • Derivatives of reactive oxygen metabolites (d-ROMs): Indicators of oxidative species present.
  • Non-protein-bound iron (NPBI): A potent pro-oxidant capable of catalyzing oxidative damage.
  • Advanced oxidation protein products (AOPP): Markers of protein oxidation, reflecting oxidative injury.
  • Biological antioxidant potential (BAP): Measurement of antioxidant defenses.
• Validated, standardized analytical methods were used to ensure accuracy.

Key Findings

• Horses with severe equine asthma showed significantly elevated levels of NPBI in BALF compared to non-SEA horses.
• There were no statistically significant differences in the levels of d-ROMs, AOPP, or BAP between SEA and non-SEA horses.
• The elevated NPBI suggests increased local pro-oxidative conditions in the airways of SEA-affected horses, likely contributing to oxidative stress and tissue damage.
• The absence of differences in other oxidative biomarkers indicates that NPBI may be a particularly sensitive marker of oxidative imbalance in SEA.

Implications

• The increased pro-oxidative potential in SEA supports the role of oxidative stress mechanisms in the pathophysiology of equine asthma.
• Biomarkers measured in BALF can help characterize the disease and potentially guide diagnosis and treatment by highlighting oxidative imbalance.
• NPBI might represent a useful biomarker for monitoring disease progression or therapeutic responses in horses with SEA.
• Understanding oxidative stress in SEA could lead to antioxidant-based therapeutic strategies to mitigate lung damage.

Limitations and Further Research

• This study was preliminary with a relatively small sample size (21 horses), so results should be confirmed with larger cohorts.
• Only a subset of potential oxidative biomarkers was evaluated; future studies could explore a broader panel.
• Longitudinal studies could assess changes in oxidative markers over the course of disease and treatment.

Summary

• This research provides evidence that oxidative stress, specifically elevated non-protein-bound iron, is associated with severe equine asthma in leisure horses.
• Measuring redox biomarkers in bronchoalveolar lavage fluid offers a window into the pulmonary oxidative environment, improving understanding and characterization of the disease.
• These preliminary findings lay the groundwork for further investigations into antioxidant therapies and biomarker-based diagnostics in equine respiratory health.